Advertisement

Pharmacy

Advertisement

U.S. House progressive caucus members invited executives from six pharma companies to testify on Capitol Hill next week about what the lawmakers deem "unjustifiable" price increases, according to STAT news.

While a large majority of hospitals obtain non-patient specific compounded drugs from FDA-designated outsourcing facilities, 11 percent of them obtained drugs from unregistered compounders, according to a new report from the HHS Office of the Inspector General.

Advertisement